REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/23/2025
Back to search
Official data from USPTO
METIMEDI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
06/24/2025
Trademark type
Word
Nice classes
5, 42
Filing date
11/15/2019
Registration date
06/23/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/23/2020
Last transaction
06/24/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
03
Owner location
Incheon, KR
Examiner
GILBERT, REBECCA
Law office
L30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
MetiMedi Pharmaceuticals Co., Ltd.
Representatives
N. Christopher Norton ArentFox Schiff LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Anti-cancer preparations; Pharmaceutical agents affecting metabolism; Pharmaceutical preparations for immunity adjustment; Vaccines; Pharmaceutical agents for regenerating cells; Anti-inflammatory preparations; Pharmaceutical agents affecting digestive organs; Cardiovascular pharmaceutical preparations; Chemical preparations for pharmaceutical purposesfor the diagnosismonitoringtreatment and prevention of immune system related diseasescancerinfectious diseasesinflammatory disorders and oncological disorders; Chemico-pharmaceutical preparationsfor the diagnosismonitoringtreatment and prevention of immune system related diseasescancerinfectious diseasesinflammatory disorders and oncological disorders; Pharmaceuticals for medical purposes for the diagnosismonitoringtreatment and prevention of immune system related diseasescancerinfectious diseasesinflammatory disorders and oncological disorders; Antibacterial substances for medical purposes; Antibodies for medical purposes for the treatment of immune system related diseasescancerinfectious diseasesinflammatory disorders and oncological disorders; Chemical preparations for medical purposefor the diagnosismonitoringtreatment and prevention of immune system related diseasescancerinfectious diseasesinflammatory disorders and oncological disorders; Diagnostic kits for medical diagnostic purposes comprising reagents for use in disease testinghealth monitoring and more generallypredictive and preventive medicine in the fields of detecting immune system related diseasescancerinfectious diseasesinflammatory disorders and oncological disorders; Diagnostic pharmaceutical preparations for medical purposes; Antibiotics; Tumor suppressing agents; Chemotherapeutics
Class 42
Research and development of vaccines and medicines; Crude medicines research; Medical and scientific research on adult diseases; Medical and scientific research on cancer; Pharmaceutical products development; Research on the subject of pharmaceuticals; Pharmaceutical product evaluation; Consultancy pertaining to pharmacology; Research for medical products; Medical research; Chemistry serviceschemistry consultationresearch in the field of chemistrylaboratory research and analysis in the field of chemistry; Chemical research and analysis; Research and development of medical products for others
Publications
History of USPTO decisions and trademark events.
30 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/17/2022
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
03/17/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
03/17/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/17/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/17/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
06/23/2020
ISPO
WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST
04/15/2020
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
04/13/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/07/2020
PUBO
PUBLISHED FOR OPPOSITION
04/07/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/18/2020
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/04/2020
CHPB
POST PUBLICATION AMENDMENT - ENTERED
03/04/2020
ALIE
ASSIGNED TO LIE
03/02/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/25/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/25/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
02/25/2020
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
02/25/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/25/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/25/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/25/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/24/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
02/24/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/24/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
02/24/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/24/2020
DOCK
ASSIGNED TO EXAMINER
02/20/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/21/2019
NWAP
NEW APPLICATION ENTERED
11/19/2019
Continuous trademark protection
Get notified about every new filing that threatens METIMEDI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.